My Treatment Approach: Improving Chronic Lymphocytic Leukemia Management and Treatment Outcomes : Episode 14
Opinion
Video
Updates in CLL Treatment Strategies with Noncovalent BTKis
Author(s):
Highlighting recent clinical trial data on pirtobrutinib in patients with chronic lymphocytic leukemia, the panel shares their experience utilizing it in clinical practice.
Video content above is prompted by the following:
- Please comment on the recent FDA approval of pirtobrutinib in patients with CLL who have received at least 2 prior lines of therapy, and briefly highlight key data from BRUIN that led to this approval.
Related Videos
Related Content
